S-EPMC10413039 - Selpercatinib in patients with RET fusion positive non-small cell lung cancer: updated follow-up of the LIBRETTO-001 phase I/II trial - OmicsDI

Unknown

Dataset Information

Selpercatinib in patients with RET fusion positive non-small cell lung cancer: updated follow-up of the LIBRETTO-001 phase I/II trial

ABSTRACT:

SUBMITTER:

PROVIDER: S-EPMC10413039 | biostudies-literature | 2023 May

REPOSITORIES: biostudies-literature